Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hua Medicine ( (HK:2552) ) has provided an update.
Hua Medicine announced the resignation of Dr. Fangxin Li as a non-executive director and a member of the Remuneration Committee, effective June 25, 2025, due to personal work arrangements. The company expressed gratitude for Dr. Li’s contributions, and his departure is not expected to impact the company’s operations or shareholder interests.
More about Hua Medicine
Hua Medicine is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative therapies for diabetes and related metabolic diseases.
Average Trading Volume: 5,106,420
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.76B
For an in-depth examination of 2552 stock, go to TipRanks’ Overview page.